Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients
Dermatology and Therapyn=897
💡
In high‑risk cSCC, integrating 40‑GEP results with BWH/AJCC8/NCCN staging improves metastatic risk stratification, supporting more risk‑aligned...
Clinical insight